OCM
VCYT icon

Osterweis Capital Management’s Veracyte VCYT Stock Holding History

Osterweis Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-86
Closed -$2.95K – 316
2025
Q3 		$2.95K Hold
86
– – ﹤0.01% 270
2025
Q2 		$2.33K Buy
+86
New +$2.49K ﹤0.01% 281

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Osterweis Capital Management's VCYT Position: Q4 2025 in Review

Osterweis Capital Management sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 86 shares — an estimated $2.95K sold.

Osterweis Capital Management first reported a position in VCYT in Q2 2025 and held it in 2 quarters. The position peaked at $2.95K in Q3 2025. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Osterweis Capital Management reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Osterweis Capital Management sold 86 Veracyte shares in Q4 2025, an estimated $2.95K.
  • Osterweis Capital Management first reported a position in Veracyte in Q2 2025 and held it in 2 quarters.
  • Osterweis Capital Management's Veracyte position peaked at $2.95K in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Osterweis Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.